Trials / Completed
CompletedNCT04100421
Exposure Of Bisphenol Analogues In Chronic Kidney Disease and Dialysis Patients
Study on the Level of Bisphenol Compounds in Patients With Chronic Kidney Disease and Renal Replacement Therapy and Relationship Between Bisphenols and Dialyzer Membrane
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 154 (actual)
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
In this retrospective study, the serum levels of Bisphenol A (BPA) and three BPA analogs, namely, bisphenol B (BPB), bisphenol S (BPS), and bisphenol F (BPF), in patients with CKD, patients on dialysis therapy and healthy control were investigated to find out if BPA and BPA analogs accumulates in patients with chronic kidney disease (CKD), and if hemodialysis filters contribute to bisphenol burden in patients on hemodialysis (HD).
Conditions
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2017-12-30
- Completion
- 2018-06-30
- First posted
- 2019-09-24
- Last updated
- 2019-09-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04100421. Inclusion in this directory is not an endorsement.